Clear Street’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,218
| Closed | -$9.02K | – | 871 |
|
|
2024
Q1 | $9.02K | Sell |
6,218
-44,992
| -88% | -$65.2K | ﹤0.01% | 424 |
|
|
2023
Q4 | $5.12K | Hold |
51,210
| – | – | ﹤0.01% | 435 |
|
|
2023
Q3 | $7.68K | Buy |
51,210
+3,867
| +8% | +$580 | ﹤0.01% | 554 |
|
|
2023
Q2 | $4.26K | Sell |
47,343
-1,167
| -2% | -$105 | ﹤0.01% | 724 |
|
|
2023
Q1 | $2.67K | Buy |
48,510
+16,489
| +51% | +$907 | ﹤0.01% | 771 |
|
|
2022
Q4 | $1K | Buy |
32,021
+15,749
| +97% | +$492 | ﹤0.01% | 911 |
|
|
2022
Q3 | $1K | Hold |
16,272
| – | – | ﹤0.01% | 1009 |
|
|
2022
Q2 | $2K | Buy |
16,272
+16,045
| +7,068% | +$1.97K | ﹤0.01% | 836 |
|
|
2022
Q1 | $0 | Buy |
+227
| New | – | ﹤0.01% | 515 |
|